India · Delayed Price · Currency is INR Tatva Chintan Pharma Chem Statistics
Total Valuation
BOM:543321 has a market cap or net worth of INR 46.58 billion. The enterprise value is 47.69 billion.
| Market Cap | 46.58B |
| Enterprise Value | 47.69B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Sep 11, 2026 |
Share Statistics
| Current Share Class | 23.39M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 74.16% |
| Owned by Institutions (%) | 6.71% |
| Float | 6.04M |
Valuation Ratios
The trailing PE ratio is 90.65 and the forward PE ratio is 60.61.
| PE Ratio | 90.65 |
| Forward PE | 60.61 |
| PS Ratio | 8.38 |
| PB Ratio | 5.96 |
| P/TBV Ratio | 6.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 147.92 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 92.82 |
| EV / Sales | 8.58 |
| EV / EBITDA | 43.71 |
| EV / EBIT | 68.45 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.10 |
| Debt / FCF | -1.46 |
| Interest Coverage | 15.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.80% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.01M |
| Profits Per Employee | 647,970 |
| Employee Count | 793 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543321 has paid 176.35 million in taxes.
| Income Tax | 176.35M |
| Effective Tax Rate | 25.55% |
Stock Price Statistics
The stock price has increased by +80.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +80.97% |
| 50-Day Moving Average | 1,703.04 |
| 200-Day Moving Average | 1,366.18 |
| Relative Strength Index (RSI) | 64.86 |
| Average Volume (20 Days) | 5,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543321 had revenue of INR 5.56 billion and earned 513.84 million in profits. Earnings per share was 21.97.
| Revenue | 5.56B |
| Gross Profit | 3.15B |
| Operating Income | 696.82M |
| Pretax Income | 690.19M |
| Net Income | 513.84M |
| EBITDA | 1.09B |
| EBIT | 696.82M |
| Earnings Per Share (EPS) | 21.97 |
Balance Sheet
The company has 87.91 million in cash and 1.20 billion in debt, with a net cash position of -1.12 billion.
| Cash & Cash Equivalents | 87.91M |
| Total Debt | 1.20B |
| Net Cash | -1.12B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.82B |
| Book Value Per Share | 334.03 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 314.89 million and capital expenditures -1.14 billion, giving a free cash flow of -822.85 million.
| Operating Cash Flow | 314.89M |
| Capital Expenditures | -1.14B |
| Depreciation & Amortization | 394.28M |
| Net Borrowing | 839.86M |
| Free Cash Flow | -822.85M |
| FCF Per Share | n/a |
Margins
Gross margin is 56.57%, with operating and profit margins of 12.53% and 9.24%.
| Gross Margin | 56.57% |
| Operating Margin | 12.53% |
| Pretax Margin | 12.41% |
| Profit Margin | 9.24% |
| EBITDA Margin | 19.62% |
| EBIT Margin | 12.53% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.19% |
| Shareholder Yield | 0.30% |
| Earnings Yield | 1.10% |
| FCF Yield | -1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:543321 is 1,442.50, which is -23.44% lower than the current price. The consensus rating is "Hold".
| Price Target | 1,442.50 |
| Price Target Difference | -23.44% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 24.81% |
| EPS Growth Forecast (3Y) | 49.19% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |